Finally, we analyzed the core intersection gene CASP8 from the perspectives of immune checkpoints, immune cell infiltration, prognosis, and protein expression, which unveiled that CASP8 can be used as a novel potential glioma prognosis biomarker. The gene discussed is CASP8; the disease is glioma.